Now Moderna vaccine sparks blood clot fears as patient shares how he thought he was going to die
Jeff Johnson, 49, of Brighton, Colorado, experienced blood clots, known as deep vein thrombosis, in his left leg one week after he received the Moderna coronavirus vaccine (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2021 Category: Consumer Health News Source Type: news

Management of patients presenting to the Emergency Department/ Acute Medicine with symptoms, RCEM
The condition of concern is Covid-19 Vaccine induced Thrombosis and Thrombocytopenia (VITT). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 16, 2021 Category: Consumer Health News Source Type: news

Guidance produced from the Expert Haematology Panel (EHP) focussed on Covid-19 Vaccine induced Thrombosis and Thrombocytopenia (VITT), British Society of Haematology
There are currently no robust data to inform management of this condition. In the absence of evidence, these are pragmatic guidelines based on experience of managing alternative similar conditions and the theoretical risks and benefits of interventions. As evidence emerges, recommendations are expected to change. Patient management should be individualised according to specific circumstances. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 16, 2021 Category: Consumer Health News Source Type: news

Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
The chance of developing cerebral venous sinus thrombosis was nearly 10 times higher in the two weeks following a diagnosis of SARS-CoV-2 infection than after receiving an mRNA vaccine, a data... (Source: The Scientist)
Source: The Scientist - April 16, 2021 Category: Science Tags: News & Opinion Source Type: news

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests
The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight to ten times higher than after receiving a COVID-19 vaccination, researchers have said. (Source: GP Online News)
Source: GP Online News - April 16, 2021 Category: Primary Care Tags: Clinical News Source Type: news

Vaccines Carry Lower Risk for Rare Blood Clots Than COVID: Study Vaccines Carry Lower Risk for Rare Blood Clots Than COVID: Study
The risk of developing cerebral venous thrombosis from COVID-19 was"many-fold" higher than from receiving the AstraZeneca/Oxford or the vaccines from Pfizer and Moderna, researchers have concluded.Medscape News UK (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 16, 2021 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Coronavirus: Study finds CVST blood clot risk is 10 times higher after Covid than after vaccination
An Oxford University study estimated 39 people out of a million develop cerebral venous sinus thrombosis (CVST) after having Covid-19, compared to four to five per million after a vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2021 Category: Consumer Health News Source Type: news

Vaccine ban outrage: '10x more likely to get brain blood clot from coronavirus than a jab'
A BLOOD clot is 10 times more likely if you catch coronavirus than if you have any of the Covid vaccines, an Oxford study has found. In particular, coming in contact with SARS-CoV-2 unprotected and unvaccinated puts you at greater risk of cerebral venous sinus thrombosis than any coronavirus vaccine. (Source: Daily Express - Health)
Source: Daily Express - Health - April 15, 2021 Category: Consumer Health News Source Type: news

The data showed that about 4 in every 1 million people who get the American-made vaccines experience cerebral venous thrombosis (CVT),...
Research by Oxford University suggests all major vaccines carry a similar risk of rare clots, and all seem to have much lower risk than... (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2021 Category: Consumer Health News Source Type: news

Pause on J & J Vaccination in U.S. Continues as CDC Committee Asks for More Data
After federal health agencies in the U.S. recommended a temporary halt on using the Johnson & Johnson-Janssen COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) on April 14 convened a 13-member Advisory Committee on Immunization Practices (ACIP) to review the six reports of unusual blood clots occurring in people vaccinated with the shot. The ACIP sets policies for how any approved or, in the case of COVID-19, authorized, vaccines are to be used—when and how the shots should be given and to which age groups. After the meeting, the CDC said it would continue to recommend the pause. The committ...
Source: TIME: Health - April 15, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Rare blood clotting risk more for COVID-19 than for vaccines: Oxford study
The risk of rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is several times higher than post-vaccination, according to a study unveiled on Thursday. (Source: The Economic Times)
Source: The Economic Times - April 15, 2021 Category: Consumer Health News Source Type: news

What you should do if you’ve received the Johnson & Johnson coronavirus vaccine
Six women who had the vaccine suffered from cerebral venous sinus thrombosis, a rare form of stroke. Here’s what to know about symptoms of blood clots if you received the vaccine. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 13, 2021 Category: Consumer Health News Authors: Lenny Bernstein Source Type: news

Johnson & Johnson Covid-19 Vaccine Rollout Is Paused - How Much Should You Worry?
The FDA and CDC announced a pause on the rollout of J&J vaccine out of the old “abundance of caution” following reports of six cases of Cerebral Venous Sinus Thrombosis (CVST). Is this necessary? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 13, 2021 Category: Pharmaceuticals Authors: Judy Stone, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick Coronavirus Source Type: news

Wisconsin DHS Pauses Administration of Johnson & Johnson COVID-19 Vaccine
The Wisconsin Department of Health Services (DHS) is instructing Wisconsin vaccine providers to stop administering the Johnson& Johnson COVID-19 vaccine due to a federal review of adverse side effects reported. The Centers for Disease Control (CDC) and U.S. Food and Drug Administration (FDA) issued astatementsaying six cases of a rare and severe type of blood clot called cerebral venous sinus thrombosis have been...(see release) (Source: Wisconsin DHFS Press Releases)
Source: Wisconsin DHFS Press Releases - April 13, 2021 Category: Hospital Management Authors: goodsesjfs Source Type: news

Rare Thrombosis, Thrombocytopenia Seen After AstraZeneca COVID-19 Vaccine
TUESDAY, April 13, 2021 -- While rare, thrombosis and thrombocytopenia can occur after the ChAdOx1 nCoV-19 adenoviral vector vaccine against COVID-19 (AstraZeneca), according to two reports published online April 9 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 13, 2021 Category: Pharmaceuticals Source Type: news

Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). (Source: World Pharma News)
Source: World Pharma News - April 13, 2021 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

How worried should we be about blood clots linked to AstraZeneca and J & J vaccines?
With both the AstraZeneca and Johnson& Johnson (J&J)vaccines, the reports involve extremely rare clotting, including a type of blood clot called cerebral venous sinus thrombosis (CVST), that were seen in combination with low levels of blood platelets, called thrombocytopenia. (Source: The Economic Times)
Source: The Economic Times - April 13, 2021 Category: Consumer Health News Source Type: news

AZ COVID Vaccine: Causal Link to Severe Thrombosis Established AZ COVID Vaccine: Causal Link to Severe Thrombosis Established
Two articles giving more details of the mechanism behind the reaction and recommendations on diagnosis/treatment are now published. Medscape talks to experts on how this may affect use of the vaccine.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 12, 2021 Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news

Two New Studies Point to How AstraZeneca ’s COVID-19 Vaccine Is Linked to Blood Clots
In two papers published in the New England Journal of Medicine (NEJM), researchers in Europe provide the most detailed explanation yet for what is behind the clotting side effects reported among people getting vaccinated with the AstraZeneca COVID-19 shot. In both papers, researchers found that people getting the vaccine had higher levels of antibodies directed against a cluster of immune-related cells that the body might form in response to the vaccine. These clusters include platelets, which help blood to clot when you get cut or injured, and the antibodies stick to the platelet-complex and form dangerous clots that can ...
Source: TIME: Health - April 9, 2021 Category: Consumer Health News Tags: Uncategorized COVID-19 Source Type: news

How worried should we be about links of blood clots to AstraZeneca's vaccine?
The EMA said its vaccine side effects monitoring system, as of April 4, had received 169 reports of cases of cerebral venous sinus thrombosis (CVST), or clots in blood vessels exiting the brain, and 53 cases of splanchnic vein thrombosis (SVT), or clotting in veins in the abdomen. (Source: The Economic Times)
Source: The Economic Times - April 9, 2021 Category: Consumer Health News Source Type: news

Cerebral Venous Sinus Thrombosis symptoms: What are the warning signs of the blood clot?
CEREBRAL venous sinus thrombosis is a blood clot in the dural venous sinuses, and the AstraZeneca vaccine has been banned in several European countries over fears of a link to the condition. What are the symptoms of sinus thrombosis? (Source: Daily Express - Health)
Source: Daily Express - Health - April 8, 2021 Category: Consumer Health News Source Type: news

EMA Again Reassures on AstraZeneca COVID Vaccine EMA Again Reassures on AstraZeneca COVID Vaccine
But the agency says it cannot rule out a link between rare and serious cases of thrombosis with thrombocytopenia with the vaccine.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 7, 2021 Category: Neurology Tags: Infectious Diseases News Source Type: news

No Increase Seen in Outpatient VTE for SARS-CoV-2-Positive Patients
TUESDAY, April 6, 2021 -- The incidence of outpatient venous thromboembolism (VTE) is similar among symptomatic patients with a positive versus negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test, according to a research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 6, 2021 Category: Pharmaceuticals Source Type: news

European Medicines Agency's top official links AstraZeneca vaccine and thrombosis
After several countries suspended the use of the jab -- including Italy -- the EMA declared that the benefits outweigh the risks and it should remain in use. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 6, 2021 Category: Pharmaceuticals Source Type: news

Thromboembolism and the OxfordAstraZeneca COVID-19 vaccine: side-effect or coincidence?, The Lancet
Danish registry study (n=4, 915 ,426, 9 years of data) suggests that the reported number of thromboembolic events with the AZ vaccine does not seem to be increased vs incidence rates from the entire Danish population before the introduction of the vaccination programme. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 1, 2021 Category: Consumer Health News Source Type: news

High thrombotic risk in cancer patients receiving immunotherapy
(Medical University of Vienna) In a study recently published in the leading journal " Blood " , researchers at MedUni Vienna provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment. The main finding is that, during the course of treatment, approximately 13% of patients develop a venous thromboembolism, that is to say a deep vein thrombosis or pulmonary embolism, and approximately 2% develop a thrombosis in the arterial system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 31, 2021 Category: Cancer & Oncology Source Type: news

What Are Indications for a Ileostomy?
Discussion There are three types of inflammatory bowel disease (IBD): Crohn’s disease (CD) – can affect entire gastrointestinal tract but often is discontinuous (i.e., has skipped areas), has transmural inflammation and disease, has granulomas Ulcerative colitis (UC) – affects the colon, is continuous (i.e., has no skipped areas) and has superficial mucosal ulcerations Unclassified IBD – has chronic colitis but not specific features of CD or UC The specific pathogenesis appears to be multifactorial with having a genetic predisposition (1.6 – 30% risk of developing UC if patient has first deg...
Source: PediatricEducation.org - March 29, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

What Is the Difference Between a Thrombus and a Blood Clot?
Title: What Is the Difference Between a Thrombus and a Blood Clot?Category: Diseases and ConditionsCreated: 3/22/2021 12:00:00 AMLast Editorial Review: 3/22/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 22, 2021 Category: Cardiology Source Type: news

MHRA confirms people should continue to receive COVID-19 vaccine AstraZeneca, MHRA (published 18th March 2021)
Following rigorous scientific review of all available data, MHRA said available evidence does not suggest venous thromboembolism is caused by COVID-19 Vaccine AstraZeneca and benefits of the vaccines against COVID-19 continue to outweigh any risks. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 19, 2021 Category: Consumer Health News Source Type: news

What is 'CSVT'? The extremely rare blood clot which affected five Brits vaccinated with Oxford's jab
Five out of 11million Britons given the Oxford vaccine have developed cerebral sinus vein thrombosis (CSVT). The cases were all men aged between 19 and 59 and one was fatal. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2021 Category: Consumer Health News Source Type: news

MHRA confirms that people should continue to receive the COVID-19 vaccine AstraZeneca
Following a rigorous scientific review of all the available data, the MHRA said that the available evidence does not suggest that blood clots in veins (venous thromboembolism) are caused by COVID-19 V (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 18, 2021 Category: Drugs & Pharmacology Source Type: news

International Society on Thrombosis and Haemostasis (ISTH) statement on the AstraZeneca COVID-19 vaccine and thrombosis, International Society on Thrombosis and Haemostasis (ISTH)
The ISTH recommends that all eligible adults continue to receive COVID-19 vaccinations, despite the recent decisions by some countries to at least temporarily suspend the use of the AstraZeneca vaccine due to reports of thrombosis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 18, 2021 Category: Consumer Health News Source Type: news

Why Countries Around the World Are Suspending Use of AstraZeneca ’s COVID-19 Vaccine
It’s the last thing public health officials want to see in the midst of a pandemic: more than two months after pharmaceutical giant AstraZeneca and Oxford University scientists released their COVID-19 vaccine, countries in Europe and elsewhere are pausing its use amid disconcerting reports that a small number of recipients have experienced blood clots, some of them fatal. The European Medicines Agency, which oversees drugs and vaccines in Europe, is expected to issue a guidance on March 18 about whether the side effects were related to the vaccine after reviewing the reports; in the meantime, it says the benefits of ...
Source: TIME: Health - March 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

How to stop blood clots - the FOUR techniques to reduce your risk of blood clots
BLOOD CLOTS have alarmed several EU nations following a loose connection made between the AstraZeneca jab and thrombosis. How do you stop a blood clot? (Source: Daily Express - Health)
Source: Daily Express - Health - March 15, 2021 Category: Consumer Health News Source Type: news

Covid-19 vaccine safe, based on scientific evidence, AstraZeneca reassures the world
It further said that, a review of available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with its vaccine has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Covid vaccine side effects: Thrombosis reported in patients - what is it?
COVID vaccine side effects: Thrombosis relates to blood clots which can be deadly and has been reported by people in Austria after having the Oxford-AstraZeneca vaccine. Why would this occur? (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2021 Category: Consumer Health News Source Type: news

AstraZeneca says 'no evidence' of higher blood clots risk from vaccine
"An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country" from the jab, a company spokesperson said. (Source: The Economic Times)
Source: The Economic Times - March 12, 2021 Category: Consumer Health News Source Type: news

Lipid presentation by the protein C receptor links coagulation with autoimmunity
Antiphospholipid antibodies (aPLs) cause severe autoimmune disease characterized by vascular pathologies and pregnancy complications. Here, we identify endosomal lysobisphosphatidic acid (LBPA) presented by the CD1d-like endothelial protein C receptor (EPCR) as a pathogenic cell surface antigen recognized by aPLs for induction of thrombosis and endosomal inflammatory signaling. The engagement of aPLs with EPCR-LBPA expressed on innate immune cells sustains interferon- and toll-like receptor 7–dependent B1a cell expansion and autoantibody production. Specific pharmacological interruption of EPCR-LBPA signaling attenua...
Source: ScienceNOW - March 11, 2021 Category: Science Authors: Müller-Calleja, N., Hollerbach, A., Royce, J., Ritter, S., Pedrosa, D., Madhusudhan, T., Teifel, S., Meineck, M., Häuser, F., Canisius, A., Nguyen, T. S., Braun, J., Bruns, K., Etzold, A., Zechner, U., Strand, S., Radsak, M., Strand, D., G Tags: Immunology, Medicine, Diseases, Online Only r-articles Source Type: news

Primordial GATA6 macrophages function as extravascular platelets in sterile injury
In this study, we used intravital microscopy to show that cavity macrophages in fluid rapidly form thrombus-like structures in response to injury by means of primordial scavenger receptor cysteine-rich domains. Aggregates of cavity macrophages physically sealed injuries and promoted rapid repair of focal lesions. In iatrogenic surgical situations, these cavity macrophages formed extensive aggregates that promoted the growth of intra-abdominal scar tissue known as peritoneal adhesions. (Source: ScienceNOW)
Source: ScienceNOW - March 4, 2021 Category: Science Authors: Zindel, J., Peiseler, M., Hossain, M., Deppermann, C., Lee, W. Y., Haenni, B., Zuber, B., Deniset, J. F., Surewaard, B. G. J., Candinas, D., Kubes, P. Tags: Immunology, Medicine, Diseases, Online Only r-articles Source Type: news

New ASH Guidelines: VTE Prevention, Treatment in Cancer Patients New ASH Guidelines: VTE Prevention, Treatment in Cancer Patients
The American Society of Hematology has issued new guidelines on the use of thromboprophylaxis for ambulatory patients receiving cancer chemotherapy who are at low venous thromboembolism (VTE) risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 3, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ASH Issues Guidance for Preventing, Treating VTE in Cancer
MONDAY, March 1, 2021 -- In a clinical guideline from the American Society of Hematology, published online Feb. 11 in Blood Advances, recommendations are presented for the prevention and treatment of venous thromboembolism (VTE) in patients with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 1, 2021 Category: Pharmaceuticals Source Type: news

Who Gets Pott ’ s Puffy Tumor?
Discussion Pott’s puffy tumor (PPT) was first described by Sir Percivall Pott in 1775 and who also described other orthopaedic and oncological diseases subsequently named for him. “It is a subperiosteal abscess of the anterior wall of the frontal sinus associated with underlying frontal osteomyelitis.” The tender edema and swelling of the forehead is the sign of PPT. Associated fever, headache, and rhinorrhea along with similar problems such as postnasal drip or nasal congestion are common. Associated ophthalmological problems include peri-orbital or eyelid edema and/or preseptal cellulitis. Ptosis and di...
Source: PediatricEducation.org - March 1, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis, Thorax
This meta-analysis of 102 studies (n=64503) found patients admitted to the ICU for severe COVID-19 had a high risk of VTE. Further studies are needed to determine the specific effects of COVID-19 on the risk of thrombosis in less severe forms of the disease. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 25, 2021 Category: Consumer Health News Source Type: news

DVT: What People Who ’ve Had It Want You to Know
Potentially life-threatening clots that form in the veins deep within your body can happen to anyone. Even young and active people can get deep vein thrombosis (DVT). People who’ve had it have some things they want you to know: (Source: WebMD Health)
Source: WebMD Health - February 23, 2021 Category: Consumer Health News Source Type: news

What Is the Difference Between Thrombus and Embolism?
Title: What Is the Difference Between Thrombus and Embolism?Category: Diseases and ConditionsCreated: 2/17/2021 12:00:00 AMLast Editorial Review: 2/17/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 17, 2021 Category: Cardiology Source Type: news

How inflammatory signalling molecules contribute to carcinogenesis
(Medical University of Vienna) A team of MedUni Vienna researchers led by Johannes A. Schmid at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, has managed to identify a previously unknown molecular connection between an inflammatory signalling molecule and one of the main oncogenes. The study has been published in the leading journal 'Molecular Cancer'. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 17, 2021 Category: Cancer & Oncology Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe CO...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, wit...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

What Are the Symptoms of Thrombosis?
Title: What Are the Symptoms of Thrombosis?Category: Diseases and ConditionsCreated: 1/29/2021 12:00:00 AMLast Editorial Review: 1/29/2021 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - January 29, 2021 Category: Cardiology Source Type: news

Venous thromboembolism in adults
This quality standard published by NICE covers diagnosing and treating venous thromboembolism (VTE) in adults. (Source: NHS Networks)
Source: NHS Networks - January 29, 2021 Category: UK Health Source Type: news